Fundamentals data is not available for this company.
| Year Ending | Revenue ($m) | Pre-tax ($m) | EPS | P/E | PEG | EPS Grth. | Div | Yield |
|---|---|---|---|---|---|---|---|---|
| 31-Dec-26 | 242.58 | (21.46) | (4.50)¢ | n/a | n/a | n/a | n/a | 0.0% |
| 31-Dec-27 | 381.91 | 39.32 | 5.67¢ | 29.1 | n/a | n/a | n/a | 0.0% |
Copyright © 2026 FactSet Research Systems Inc. All rights reserved.
No recent information was found.
| Geron explains setback on stem cell study | 28-Aug-2009 | BayArea.com |
| Geron sees progress in stem-cell therapy | 27-Aug-2007 | BayArea.com |
| Stock Ticker | 12-Jun-2007 | BayArea.com |
| Currency | US Dollars |
| Share Price | $ 1.65 |
| Change Today | $ 0.02 |
| % Change | 1.23 % |
| 52 Week High | $2.80 |
| 52 Week Low | $1.07 |
| Volume | 12,683,400 |
| Shares Issued | 186.46m |
| Market Cap | $307.65m |
| RiskGrade | 277 |
| Strong Buy | 2 |
| Buy | 2 |
| Neutral | 3 |
| Sell | 1 |
| Strong Sell | 0 |
| Total | 8 |

| Time | Volume / Share Price |
| 15:59 | 300 @ $1.66 |
| 15:59 | 4,100 @ $1.66 |
| 15:59 | 251 @ $1.66 |
| 15:59 | 300 @ $1.66 |
| 15:59 | 100 @ $1.66 |
You are here: research